INTERNATIONAL SPEAKERS
INTERNATIONAL SPEAKERS
Christoph Lees is Reader in Obstetrics and Fetal Medicine at Imperial College London; Honorary Consultant in Obstetrics and Head of Fetal Medicine at Imperial College Healthcare NHS Trust and Centre for Fetal Care, Queen Charlotte's and Chelsea Hospital, London.
h-index: 67
Cardiovascular adaptation in pre-eclampsia and fetal growth restriction
Therapy for acute pre-eclampsia
TRUFFLE 1 and 2 studies: Fetal Doppler Ultrasound and Fetal Growth Restriction
High Intensity Focused Ultrasound and non-invasive fetal surgical intervention in monochorionic (MCDA) twins
Intrapartum ultrasound and the Sonopartogram
3D facial and brain morphology in prenatal diagnosis
Professor Institute of Biomedical Sciences China Medical University (Taiwan). Expertise in Molecular and Cellular Oncology, Cancer Cell Metabolism, Cell Stress Responsive Signaling, and Cancer Stem Cells.
Dr. Tan’s lab is studying tumor promoting genes and tumor-suppressing genes in mediating cancer metabolism, signal transduction, apoptosis, metastasis, and resistance to therapeutic agents. Another emphasis of his study is on the deregulation of microRNA in cancer progression and therapeutic resistance.
The ultimate goal of Dr. Tan’s research is to translate the knowledge acquired in the laboratory into future novel therapeutics.
Prof Gus Dekker is currently the Academic Head of the Department of Obstetrics & Gynaecology, Northern Adelaide Local Health Network (NALHN). From 1998-2014 Dekker has been the Professor and Clinical Director of the Women and Children's Division at Lyell McEwin Hospital, Northern Campus University of Adelaide. In December 2014, Dekker stepped down as clinical director in order to further focus on clinical research.
His areas of specific interest include the genetics and immunology of preeclampsia, prediction and prevention of preeclampsia, prediction and management of preterm labour and the role of genetic and acquired thrombophilic disorders in the causation of adverse pregnancy outcomes. He was the first to identify the role of genetic and acquired thrombophilia as important risk factors for early-onset preeclampsia (Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, van Geijn HP. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042). His research on the use of nifedipine in the management of preterm labour, led to this drug being the currently most used drug for this common condition.
Dr Renuka Shanmugalingam is an Australian trained Nephrologist and Obstetric Medicine Physician. She has completed her PhD in hypertensive disorders of pregnancy and has been awarded 3 national and international awards for the studies conducted as part of her PhD.
Dr Shanmugalingam is passionate about teaching and is a frequent invited speaker at national and international conferences. She is also the clinical sub-dean for Western Sydney University’s Bankstown Clinical School.
Dr Shanmugalingam is an executive council member of the Society of Obstetric Medicine Australia and New Zealand and heads the education committee of SOMANZ. She is also the lead in developing SOMANZ’s updated Guideline in Hypertensive Disorders of Pregnancy 2023.
Dr Shanmugalingam prides herself in providing patient centred, evidence-based care. Her area of expertise includes:
General nephrology
Chronic kidney disease care
Acute kidney injury
Dialysis care (home/hospital-based dialysis)
Hypertension
Renal stones
Renal obstetrics
Hypertension in pregnancy
Preconception care (including preconception renal review)
Postpartum care (including post preeclampsia review)